Trial in progress
Enfortumab vedotin across several cancers
Finished collecting data February 2025Results for this cancer not yet found in published reports
What is being tested
Enfortumab vedotin, a bladder cancer drug aimed at nectin-4, in several other advanced cancers including esophageal.
Why it matters
Shows whether a proven bladder cancer drug has any activity here.
Last reviewed 2026-11-14 by the Find a Trial editorial team.
Information on this page is for educational purposes and is not medical advice.
Always consult qualified healthcare professionals about clinical trial participation.